Condensed Consolidated Statements of Comprehensive Income (Loss) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Revenues
Revenues	$ 145,534	$ 92,761
Expenses:
Cost of product sales	4,568	1,265
Research and development	37,270	46,493
Selling, general and administrative	82,469	59,491
Total operating expenses	124,307	107,249
Total other comprehensive income (loss)	211	(566)
Net comprehensive income (loss)	243	(35,945)
Other income (expense):
Income (loss) from operations	21,227	(14,488)
Interest income	3,024	4,031
Interest expense	(23,494)	(24,506)
Foreign currency gains (losses), net	1	(51)
Total other expense	(20,469)	(20,526)
Income (loss) before income taxes	758	(35,014)
Income tax expense	726	365
Net income (loss)	$ 32	$ (35,379)
Basic net loss per common share (in usd per share)	$ 0.00	$ (0.17)
Weighted average shares outstanding, basic (in shares)	208,882	206,064
Diluted net loss per common share (in usd per share)	$ 0.00	$ (0.17)
Weighted average shares outstanding, diluted (in shares)	215,261	206,064
Other Comprehensive Income (Loss), Net of Tax [Abstract]
Foreign currency translation adjustment	$ 366	$ (253)
Unrealized loss on available for sale investments	$ (155)	$ (313)